Senseonics (NASDAQ:SENS) Price Target Raised to $11.00

Senseonics (NASDAQ:SENS) had its price target boosted by Barclays from $10.00 to $11.00 in a research report report published on Tuesday,Benzinga reports. They currently have an equal weight rating on the stock.

A number of other research analysts also recently commented on SENS. TD Cowen reiterated a “buy” rating and issued a $15.00 price objective on shares of Senseonics in a report on Tuesday, October 27th. HC Wainwright restated a “buy” rating and set a $14.00 target price on shares of Senseonics in a research note on Tuesday. Mizuho lowered their price target on Senseonics from $20.00 to $18.00 and set an “outperform” rating for the company in a report on Wednesday, July 15th. Raymond James Financial upgraded shares of Senseonics from an “underperform” rating to a “market perform” rating in a research note on Tuesday. Finally, Wall Street Zen upgraded shares of Senseonics from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 8th. Three equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Senseonics presently has a consensus rating of “Hold” and a consensus price target of $14.40.

Senseonics Trading Down 3.6%

NASDAQ SENS opened at $10.04 on Tuesday. The company has a debt-to-equity ratio of 0.70, a current ratio of 5.92 and a quick ratio of 6.40. The firm has a 50 day simple moving average of $9.16 and a 200-day simple moving average of $7.31. Senseonics has a one year low of $4.79 and a one year high of $13.98.

Senseonics (NASDAQ:SENS) last issued its quarterly earnings results on Monday, November 9th. The company reported ($0.50) earnings per share for the quarter, missing the consensus estimate of ($0.49) by ($0.01). Senseonics had a negative return on equity of 186.11% and a negative net margin of 204.01%. The company had revenue of $19.56 million for the quarter. As a group, equities analysts forecast that Senseonics will post -2.30 earnings per share for the current year.

Insider Activity

In other Senseonics news, Director Douglas Roeder acquired 13,953 shares of the stock in a transaction on Wednesday, August 19th. The shares were bought at an average cost of $8.98 per share, with a total value of $125,297.94. Following the transaction, the director owned 171,191 shares of the company’s stock, valued at approximately $1,537,295.18. This trade represents a 8.87% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 4.70% of the company’s stock.

Institutional Investors Weigh In On Senseonics

Hedge funds have recently made changes to their positions in the business. BlackRock Inc. purchased a new position in shares of Senseonics during the second quarter worth about $15,867,000. Masters Capital Management LLC increased its position in Senseonics by 100.0% in the 1st quarter. Masters Capital Management LLC now owns 500,000 shares of the company’s stock valued at $3,330,000 after acquiring an additional 250,002 shares during the period. Bank of America Corp DE acquired a new position in Senseonics in the 2nd quarter valued at about $2,241,000. Readystate Asset Management LP purchased a new stake in Senseonics during the 2nd quarter valued at approximately $574,000. Finally, Penn Capital Management Company LLC purchased a new stake in Senseonics during the 2nd quarter valued at approximately $535,000. Institutional investors and hedge funds own 12.36% of the company’s stock.

More Senseonics News

Investors following SENS have been watching these news items:

• Positive Sentiment: Other analyst headlines cite strong price-appreciation outlooks from Mizuho and Barclays, and a TD Cowen price-target increase. Mizuho forecast Barclays forecast TD Cowen target
• Neutral Sentiment: Analyst opinions are not uniformly bullish: Stifel Nicolaus assigned a Hold rating, while Raymond James upgraded SENS to Market Perform. Stifel rating Raymond James rating
• Negative Sentiment: HC Wainwright lowered estimates for Q4 2026 and Q1–Q2 2027, and reduced its FY2027 forecast to a loss of $2.13 per share from $2.05. These near-term revisions could temper the positive effect of its Buy rating, although it raised its Q3 2027 estimate.

Senseonics Company Profile

Senseonics Holdings, Inc. develops continuous glucose monitoring (CGM) technology for people with diabetes. Its Eversense systems use a small sensor implanted under the skin to measure glucose levels, an external wearable transmitter to send readings, and a mobile app to display data and provide alerts. The company’s product line includes implantable CGM systems designed for extended wear, including the Eversense 365 system, which is designed to last up to one year. Unlike many CGM products that use sensors replaced more frequently, Eversense sensors are inserted and removed by a healthcare professional.